 | Up a level |
Piccolo, Raffaele; Calabrò, Paolo; Varricchio, Attilio; Baldi, Cesare; Napolitano, Giovanni; De Simone, Ciro; Mauro, Ciro; Stabile, Eugenio; Caiazzo, Gianluca; Tesorio, Tullio; Boccalatte, Marco; Tuccillo, Bernardino; Bottiglieri, Giuseppe; Russolillo, Enrico; Lorenzo, Emilio Di; Carrara, Greta; Cassese, Salvatore; Leonardi, Sergio; Biscaglia, Simone; Costa, Francesco; ... (2023). Rationale and Design of the PARTHENOPE Trial: A Two-by-Two Factorial Comparison of Polymer-Free vs. Biodegradable-Polymer Drug-Eluting Stents and Personalized vs. Standard Duration of Dual Antiplatelet Therapy in All-Comers Undergoing PCI. American Heart Journal, 265, pp. 153-160. Elsevier 10.1016/j.ahj.2023.08.001
Costa, Francesco; Montalto, Claudio; Branca, Mattia; Hong, Sung-Jin; Watanabe, Hirotoshi; Franzone, Anna; Vranckx, Pascal; Hahn, Joo-Yong; Gwon, Hyeon-Cheol; Feres, Fausto; Jang, Yangsoo; De Luca, Giuseppe; Kedhi, Elvin; Cao, Davide; Steg, Philippe Gabriel; Bhatt, Deepak L; Stone, Gregg W; Micari, Antonio; Windecker, Stephan; Kimura, Takeshi; ... (2023). Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials. European Heart Journal, 44(11), pp. 954-968. Oxford University Press 10.1093/eurheartj/ehac706
Costa, Francesco; van Klaveren, David; Colombo, Antonio; Feres, Fausto; Räber, Lorenz; Pilgrim, Thomas; Hong, Myeong-Ki; Kim, Hyo-Soo; Windecker, Stephan; Steyerberg, Ewout W; Valgimigli, Marco (2020). A 4-item PRECISE-DAPT score for dual antiplatelet therapy duration decision-making. American Heart Journal, 223, pp. 44-47. Elsevier 10.1016/j.ahj.2020.01.014
Costa, Francesco; Brugaletta, Salvatore; Pernigotti, Alberto; Flores-Ulmanzor, Eduardo; Ortega-Paz, Luis; Cequier, Angel; Iniguez, Andres; Serra, Antoni; Jiménez-Quevedo, Pilar; Mainar, Vicente; Campo, Gianluca; Tespili, Maurizio; den Heijer, Peter; Bethencourt, Armando; Vazquez, Nicolás; van Es, Gerrit Anne; Backx, Bianca; Valgimigli, Marco; Serruys, Patrick and Sabaté, Manel (2019). Does Large Vessel Size Justify Use of Bare-Metal Stents in Primary Percutaneous Coronary Intervention? Circulation: Cardiovascular interventions, 12(9), e007705. Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.118.007705
Cammaroto, Giovanni; Costa, Francesco; Ruiz, Maria Victoria Garcia; Andò, Giuseppe; Vicini, Claudio; Montevecchi, Filippo; Galletti, Claudio; Galletti, Francesco; Valgimigli, Marco (2019). Obstructive sleep apnoea syndrome and endothelial function: potential impact of different treatment strategies-meta-analysis of prospective studies. European archives of oto-rhino-laryngology, 276(8), pp. 2331-2338. Springer 10.1007/s00405-019-05486-6
Costa, Francesco; van Klaveren, David; Steyerberg, Ewout; Valgimigli, Marco (2019). Reply: Use of Clinical Risk Score in an Elderly Population: Need for Ad Hoc Validation and Calibration. Journal of the American College of Cardiology, 74(1), pp. 162-163. Elsevier 10.1016/j.jacc.2019.05.005
Valgimigli, Marco; Garcia Garcia, Hector; Vrijens, Bernard; Vranckx, Pascal; McFadden, Eugène P; Costa, Francesco; Pieper, Karen; Vock, David M; Zhang, Min; Van Es, Gerrit-Anne; Tricoci, Pierluigi; Baber, Usman; Steg, Gabriel; Montalescot, Gilles; Angiolillo, Dominick J; Serruys, Patrick W; Farb, Andrew; Windecker, Stephan; Kastrati, Adnan; Colombo, Antonio; ... (2019). Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). European Heart Journal, 40(25), pp. 2070-2085. Oxford University Press 10.1093/eurheartj/ehy377
Costa, Francesco; Van Klaveren, David; Feres, Fausto; James, Stefan; Räber, Lorenz; Pilgrim, Thomas; Hong, Myeong-Ki; Kim, Hyo-Soo; Colombo, Antonio; Steg, Philippe Gabriel; Bhatt, Deepak L; Stone, Gregg W; Windecker, Stephan; Steyerberg, Ewout W; Valgimigli, Marco (2019). Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting. Journal of the American College of Cardiology, 73(7), pp. 741-754. Elsevier 10.1016/j.jacc.2018.11.048
Costa, Francesco; Valgimigli, Marco (2018). The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short. Cardiovascular diagnosis and therapy, 8(5), pp. 630-646. AME Publishing Company 10.21037/cdt.2018.10.01
Valgimigli, Marco; Costa, Francesco (2018). Chronic Thrombocytopenia and Percutaneous Coronary Intervention: The Virtue of Prudence. JACC. Cardiovascular Interventions, 11(18), pp. 1869-1871. Elsevier 10.1016/j.jcin.2018.06.051
Collet, Jean-Philippe; Roffi, Marco; Byrne, Robert A; Costa, Francesco; Valgimigli, Marco; Windecker, Stephan (2018). Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease: The Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 39(3), e1-e33. Oxford University Press 10.1093/eurheartj/ehx503
Valgimigli, Marco; Bueno, Héctor; Byrne, Robert A; Collet, Jean-Philippe; Costa, Francesco; Jeppsson, Anders; Jüni, Peter; Kastrati, Adnan; Kolh, Philippe; Mauri, Laura; Montalescot, Gilles; Neumann, Franz-Josef; Petricevic, Mate; Roffi, Marco; Steg, Philippe Gabriel; Windecker, Stephan; Zamorano, Jose Luis; Levine, Glenn N (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal, 39(3), pp. 213-260. Oxford University Press 10.1093/eurheartj/ehx419
Valgimigli, Marco; Bueno, Héctor; Byrne, Robert A; Collet, Jean-Philippe; Costa, Francesco; Jeppsson, Anders; Jüni, Peter; Kastrati, Adnan; Kolh, Philippe; Mauri, Laura; Montalescot, Gilles; Neumann, Franz-Josef; Petricevic, Mate; Roffi, Marco; Steg, Philippe Gabriel; Windecker, Stephan; Zamorano, Jose Luis; Levine, Glenn N (2018). 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). European journal of cardio-thoracic surgery, 53(1), pp. 34-78. Oxford University Press 10.1093/ejcts/ezx334
Valgimigli, Marco; Bueno, Héctor; Byrne, Robert A; Collet, Jean-Philippe; Costa, Francesco; Jeppsson, Anders; Jüni, Peter; Kastrati, Adnan; Kolh, Philippe; Mauri, Laura; Montalescot, Gilles; Neumann, Franz-Josef; Petricevic, Mate; Roffi, Marco; Steg, Philippe Gabriel; Windecker, Stephan; Zamorano, José Luis (2018). Special article 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Revista española de cardiología - English Edition, 71(1), p. 42. Elsevier Doyma 10.1016/j.rec.2017.11.020
Costa, Francesco; Windecker, Stephan; Valgimigli, Marco (2017). Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies. Drugs, 77(16), pp. 1733-1754. Adis International 10.1007/s40265-017-0806-1
Costa, Francesco; van Klaveren, David; James, Stefan; Heg, Dik; Räber, Lorenz; Feres, Fausto; Pilgrim, Thomas; Hong, Myeong-Ki; Kim, Hyo-Soo; Colombo, Antonio; Steg, Philippe Gabriel; Zanchin, Thomas; Palmerini, Tullio; Wallentin, Lars; Bhatt, Deepak L; Stone, Gregg W; Windecker, Stephan; Steyerberg, Ewout W; Valgimigli, Marco and PRECISE_DAPT, StudyInvestigators (2017). Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet, 389(10073), pp. 1025-1034. Elsevier 10.1016/S0140-6736(17)30397-5
Adamo, Marianna; Ariotti, Sara; Costa, Francesco; Curello, Salvatore; Moschovitis, Aris; de Vries, Ton; White, Harvey D; Windecker, Stephan; Valgimigli, Marco (2016). Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the PRISM Trial. JACC. Cardiovascular Interventions, 9(16), pp. 1667-1676. Elsevier 10.1016/j.jcin.2016.05.031
Costa, Francesco; Daemen, Joost; Diletti, Roberto; Kauer, Floris; Geuns, Robert-Jan van; Ligthart, Jurgen; Witberg, Karen; Zijlstra, Felix; Valgimigli, Marco; Van Mieghem, Nicolas M; van Leeuwen, Maarten A H (2016). Response by Costa et al to Letter Regarding Article, "The Rotterdam Radial Access Research: Ultrasound-Based Radial Artery Evaluation for Diagnostic and Therapeutic Coronary Procedures". Circulation: Cardiovascular interventions, 9(7) Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.116.003990
Andò, Giuseppe; Costa, Francesco; Trio, Olimpia; Oreto, Giuseppe; Valgimigli, Marco (2016). Impact of vascular access on acute kidney injury after percutaneous coronary intervention. Cardiovascular revascularization medicine, 17(5), pp. 333-338. Elsevier 10.1016/j.carrev.2016.03.004
Crimi, Gabriele; Leonardi, Sergio; Costa, Francesco; Adamo, Marianna; Ariotti, Sara; Valgimigli, Marco (2016). Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial. International journal of cardiology, 212, pp. 110-117. Elsevier 10.1016/j.ijcard.2016.03.033
Gargiulo, Giuseppe; Costa, Francesco; Ariotti, Sara; Biscaglia, Simone; Campo, Gianluca; Esposito, Giovanni; Leonardi, Sergio; Vranckx, Pascal; Windecker, Stephan; Valgimigli, Marco (2016). Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. American Heart Journal, 174, pp. 95-102. Elsevier 10.1016/j.ahj.2016.01.015
Ariotti, Sara; Adamo, Marianna; Costa, Francesco; Patialiakas, Athanasios; Briguori, Carlo; Thury, Attila; Colangelo, Salvatore; Campo, Gianluca; Tebaldi, Matteo; Ungi, Imre; Tondi, Stefano; Roffi, Marco; Menozzi, Alberto; de Cesare, Nicoletta; Garbo, Roberto; Meliga, Emanuele; Testa, Luca; Gabriel, Henrique Mesquita; Ferlini, Marco; Vranckx, Pascal; ... (2016). Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial. JACC. Cardiovascular Interventions, 9(5), pp. 426-436. Elsevier 10.1016/j.jcin.2015.11.015
Costa, Francesco; Adamo, Marianna; Ariotti, Sara; Ferrante, Giuseppe; Navarese, Eliano Pio; Leonardi, Sergio; Garcia-Garcia, Hector; Vranckx, Pascal; Valgimigli, Marco (2016). Left main or proximal left anterior descending coronary artery disease location identifies high-risk patients deriving potentially greater benefit from prolonged dual antiplatelet therapy duration. EuroIntervention, 11(11), e1222-e1230. Europa Digital & Publishing 10.4244/EIJY15M08_04
Udell, Jacob A; Bonaca, Marc P; Collet, Jean-Philippe; Lincoff, A Michael; Kereiakes, Dean J; Costa, Francesco; Lee, Cheol Whan; Mauri, Laura; Valgimigli, Marco; Park, Seung-Jung; Montalescot, Gilles; Sabatine, Marc S; Braunwald, Eugene; Bhatt, Deepak L (2016). Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials. European Heart Journal, 37(4), pp. 390-399. Oxford University Press 10.1093/eurheartj/ehv443
Costa, Francesco; Valgimigli, Marco (2015). Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. New England journal of medicine NEJM, 373(13), pp. 1271-1272. Massachusetts Medical Society MMS 10.1056/NEJMc1508692#SA2
Costa, Francesco; Ariotti, Sara; Valgimigli, Marco; Kolh, Philippe; Windecker, Stephan (2015). Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization: Fifty Years of Revascularization: Where Are We and Where Are We Heading? Journal of cardiovascular translational research JCTR, 8(4), pp. 211-220. Springer 10.1007/s12265-015-9632-6
Valgimigli, Marco; Costa, Francesco; Byrne, Robert; Haude, Michael; Baumbach, Andreas; Windecker, Stephan (2015). Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey. EuroIntervention, 11(1), pp. 68-74. Europa Digital & Publishing 10.4244/EIJV11I1A11
Campos, Carlos M; Costa, Francesco; Garcia-Garcia, Hector M; Bourantas, Christos; Suwannasom, Pannipa; Valgimigli, Marco; Morel, Marie-Angele; Windecker, Stephan; Serruys, Patrick W (2015). Anatomic characteristics and clinical implications of angiographic coronary thrombus: insights from a patient-level pooled analysis of SYNTAX, RESOLUTE, and LEADERS Trials. Circulation: Cardiovascular interventions, 8(4) Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.114.002279
Costa, Francesco; Tijssen, Jan G; Ariotti, Sara; Giatti, Sara; Moscarella, Elisabetta; Guastaroba, Paolo; De Palma, Rossana; Andò, Giuseppe; Oreto, Giuseppe; Zijlstra, Felix; Valgimigli, Marco (2015). Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy. Journal of the American Heart Association, 4(12) American Heart Association 10.1161/JAHA.115.002524
